IP Verse

Astrazeneca Pharmaceuticals Lp V. Cipla Limited - 3:24-cv-08167

Explore the details of the Astrazeneca Pharmaceuticals Lp V. Cipla Limited case under case number 3:24-cv-08167 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
3:24-cv-08167
Filing Date
Jul 31, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
ASTRAZENECA UK LIMITED -
CIPLA USA, INC. -
MSD INTERNATIONAL BUSINESS GMBH -
KUDOS PHARMACEUTICALS LIMITED -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 31, 2024COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15556746), Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A ('695 patent), # 2 Certification (Rule 11.2), # 3 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 07/31/2024)PACER Document
Jul 31, 2024Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024)PACER Document
Jul 31, 2024Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024)PACER Document
Jul 31, 2024Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024)PACER Document
Jul 31, 2024Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024)PACER Document
Jul 31, 2024Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (kht)PACER Document
Jul 31, 2024AO120 Patent/Trademark Form filed. (kht) (Entered: 07/31/2024)PACER Document
Jul 31, 2024SUMMONS ISSUED as to CIPLA LIMITED, CIPLA USA, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (kht) (Entered: 07/31/2024)PACER Document
Jul 31, 2024COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15556746), Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A ('695 patent), # 2 Certification (Rule 11.2), # 3 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 07/31/2024)Attachment
Jul 31, 2024COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15556746), Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A ('695 patent), # 2 Certification (Rule 11.2), # 3 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 07/31/2024)Attachment
Jul 31, 2024COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15556746), Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A ('695 patent), # 2 Certification (Rule 11.2), # 3 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 07/31/2024)Attachment